Endevica Bio Leadership Team
Russell Potterfield
CEO And Executive Chairman
Mr. Potterfield is an entrepreneur with a background in corporate strategy and design team management. He is the inventor on more than two dozen patents from his time at Battenfeld Technologies, where he created and led a design team to a successful exit.
Dr. Kenneth Gruber
Founder and Chief Scientific Officer
Dr. Gruber is a former NIH Branch Chief with a decade of experience as an NIH-funded investigator. He is the inventor of six patents protecting the intellectual property used to develop Endevica’s Cachexia treatments. He is a principal investigator on $4 million in NIH/NCI SBIR grants.
Dr. Daniel L. Marks
Chief Medical Officer and Director
Dr. Marks is an established physician scientist with decades of experience leading basic and clinical research studies, including the research program at the Daniel Marks Pediatric Research Lab at Oregon Health & Science University and Doernbecher Children’s Hospital.
Dr. Bobby Sandage
Director
Dr. Sandage is the CEO at Eclises Pharmaceuticals, General Partner at Cultivation Capital Life Sciences Venture Fund, CEO of Coronado Biosciences, VP at Covidien, EVP R&D, CSO, and head of Manufacturing at Indevus.
Gene Gerke
Director
Mr. Gerke is Treasurer and Secretary of the Board of Directors. He specializes in strategic planning and executive consultation. He is Founder of Gerke & Associates and the founder or co-founder of numerous start-ups. He is the Co-Founder and Co-President of Centennial Investors, an Angel Investing Group.